GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea - U.S. News …
2 days ago · FDA approval for Zepbound in treating sleep apnea was based on two previous Eli Lilly-sponsored trials published in the New England Journal of Medicine involving nearly 470 participants, some of ...
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
2 days ago · Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when ...
FDA approves Zepbound® (tirzepatide) as the first and only …
5 days ago · About Zepbound ® (tirzepatide) injection Zepbound ® (tirzepatide) injection is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. It is also approved in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults ...
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
5 days ago · The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...
FDA approves weight loss drug Zepbound for sleep apnea - NBC News
5 days ago · The approval is based on two trials of men and women with obesity and moderate to severe sleep apnea. In Lilly's sleep apnea research, people who took Zepbound lost around 20% of their body weight ...
GLP-1 Zepbound is approved as first drug for sleep apnea
2 days ago · The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release ...
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea
2 days ago · Lilly said its final trial evaluated sleep apnea and weight loss in those taking Zepbound, with some patients using a traditional "positive airway pressure" (PAP) mask while sleeping and others ...
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
5 days ago · The drug’s maker, Eli Lilly, announced that the agency authorized Zepbound for people with obesity and moderate to severe obstructive sleep apnea. Millions of Americans have the condition, and ...
Tirzepatide reduced sleep apnea severity by up to nearly two …
INDIANAPOLIS, April 17, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results of the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide injection (10 mg or 15 mg) significantly reduced the apnea-hypopnea index (AHI) compared to placebo, achieving the primary endpoints.
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Jun 21, 2024 · The company released additional data from two late-stage trials showing that Zepbound helped resolve obstructive sleep apnea in almost half of patients. The results add to growing evidence of...